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Urethane  (ethyl  carbamate)  is  a  broad  spectrum  carcinogen  which  has 
been demonstrated to produce neoplasms of the lungs (1), liver (2),  mesenchy- 
real tissue (3),  and skin  (4)  in at least two species,  the mouse and the  rat. 
Because of the simplicity of its chemical structure it has proved a particularly 
interesting carcinogen for those studying the mechanism of carcinogenesis  by 
classic chemical means. Studies of the carcinogenicity (5) or mitotic poisoning 
effects (6)  of various esters of carbamic acid chemically related to urethane, 
the  carcinogenicity  of  alkylated urethanes  (7),  of  potential  urethane  deg- 
radation  products  (8),  and  a  wide variety  of  general  hypnotics  (9)  have, 
however, yielded no information  upon the mechanism  of action of urethane 
other than its relation to the specificity of the molecular structure of urethane. 
Observations on the influence of urethane on enzymatic and other less discrete 
in vitro systems have not yet been correlated  with its carcinogenic  or anti- 
leukemic action though they have given rise to many interesting speculations 
(10). Because the general biological  importance of nucleic acid to the mainte- 
nance of heritable characteristics is generally recognized  and,  because of the 
nuclear poisoning  effects of urethane  (11),  much attention has been directed 
toward the carcinogen's possible influence upon nucleic acid synthesis. Recent 
experiments have discounted the assumption that urethane has a direct nucleo- 
toxic action in initiating  tumors  (5,  6,  12). Evidence perhaps in favor of an 
influence  upon  nucleic  acids,  however,  has  been  reported  by  Cowen  (13). 
Since the effect of pentosenucleotides on leucocytes is the opposite of that of 
urethane,  he  tested  the  protective  effect of these  substances upon  its  car- 
cinogenic action. Fewer pulmonary tumors developed in mice receiving multiple 
injections of these nucleotides. However,  the nucleotides were largely given 
after urethane injections had been discontinued. In addition, the tested animals 
suffered severe ill effects, thereby casting considerable doubt upon the validity 
of the results; for it is well known that the state of the animal influences greatly 
the overt occurrence and growth of tumors (14). 
* Supported by a grant (C-1741) from the National Cancer Institute, National Institutes 
of Health, United States Public Health Service. 
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Young, rapidly growing mice are much more responsive to standard doses of 
urethane than are those that are older and more slowly growing (12, 15). Since 
there is a recognized correlation in the rate of synthesis of desoxyribosenucleic 
acid and the growth rate of the body at a given time (16), it seemed worth- 
while to find out to what extent the number of tumors initiated by a  single 
injection of urethane might  be influenced by simultaneous  exposure of the 
animals  to desoxyribosenucleic acid  (DNA), ribosenucleic acid  (RNA)  their 
chemical  components,  precursors,  and  substances  influencing  their  rate  of 
synthesis. 
It will be demonstrated that a  single injection of a  DNA hydrolysate im- 
mediately prior to exposure of mice to urethane profoundly reduces the number 
of tumors initiated. Aminopterin, well known to inhibit nucleic acid synthesis 
(17),  increases the  carcinogenic activity of injected urethane.  This increase 
can be prevented by injection of a  DNA hydrolysate. Of the components of 
nucleic acid tested the pyrimidines proved the most active inhibitors. Of the 
pyrimidine precursors it  will  be  shown  that  orotic acid  and  dihydro-orotic 
acid  also  exert  profound  inhibitory influences upon  carcinogenesis  brought 
about through exposure of mice  to urethane. Ureidosuccinic acid, a  normally 
occurring  pyrimidine  precursor,  (18)  whose  chemical  structure  has  much 
resemblance  to  that  of  urethane,  reduces  the  carcinogenic  effectiveness of 
exposure of lung  tissue in dtro  to  the  intermediary elicited by injection of 
certain animals with urethane (19). 
MaleriaIs and Melkods 
Materials: 
Umthane (ethyl carbamate, c. P., Elmer and Amend, New York). Sodium desoxyribo- 
nucleate  (Nutritional Biochemicals Corporation, Cleveland). The manufacturer used the 
hot alkaline extraction method of Levine (20) in its preparation from fish spem~. It is 
depolymerized and  made up almost entirely of components the ~  of tetranucleotides. 
~r,~nopterin (Lederle, Pearl River). Adenine, uracil, thymine, orotic acid, oxaloacetic  acid, 
aspaz'dc acid, cytidylic acid, uridylic acid, cytosine, guanine, glutathione, glutamlc acid, 
methionine, cystelne, ethionine, para-aminobenzoic  acid, folic add (Nutritional Biochemlcals 
Corporation, Cleveland). Desoxycytldylic add,  thymldyllc  acid, and  $-methylcytosine 
(California Foundation for Biochemical Research, Pasadena). Uridlne-$-pbosphate (Pabst 
Industries, Milwaukee). Urea, nitrogen mustard (methyl bls-), (Merck, Rahway). Sodium 
formate (MaUinckrodt Chemical Works, New York). Aeparagine (Pfanstiehl Chemical Com- 
pany, Waukegan, ]]llnois). Acriflavin, N. Y.,  (Abbott, Chicago). B.A.L. (2, 3,-dimercapto- 
propanol), (Hynson, Westcott, and Dunning, Baltimore). 4-Amino-$-imidazole  carboxamide 
and ureidosuccinic  add synthesized by Dr. Bruce Merrifield of The Rockefeller Institute, 
New York, and were his generous  gift. Dihydro-orotic  acid was synthesized by and was the 
generous gift of Dr. Elliott Shaw of The Rockefeller  Institute, New York. 
M~kods: 
All chemicals, with the exception of urethane which was used as a 5 per cent solution in 
double distilled water, were used at the concentrations indicated in the individusl experi- ST~LD  ROOE~S  281 
merits and  as solutions made isotonic with sodium chloride. The tonicity was determined 
by calculation from the moleodsr weights and, when necessary, determined or checked by the 
response of mouse blood cells in v//ro. Unless contraindicated by the nature of the substance, 
all concentrations were used as solutions sterilized by auto.laving. The sodium desoxyribo- 
nucleate the  individual  nudeetides,  4-smino-5-imidszole carboxamide, and  ureidosuccinic 
acid were sterilized by filtration through a Berkefeld V filter. The oxaloacetic add was used 
immediately following preparation and not sterilized. 
M/ce.--Animals of the Swiss,  "A," and "C" strains were used. Both the Swiss and "A" 
strains have a high incidence of pulmonary adenomas whereas the "C" has a low incidence. 
References to the specific character of the stocks may be found in a  previous report  (12). 
In all experiments the animals tested were matched as to age, weight, sex, and strain. In all 
in vivo experiments the mice received injections calculated on a per gram basis. The weights 
of the mice were followed over the duration of the experiments at least at weekly intervals. 
All mice developing intercurrent disease, such as "chuckles"  in the Swiss and "C" strains or 
rectal prolapse in the "A"  strain, were discarded.  Also discarded were any animals whose 
weights deviated 2 gm. or more from the mean over a period of 2 consecutive weeks. All mice 
were kept ten to a  box, with mice of tested groups within the experiment distributed in the 
same box. Animals were fed Purina chow supplemented with milk-soaked bread twice a week. 
Tap water was available at liberty. In the in vivo experiments the mice were killed by decapita- 
tion after the intervals indicated in individual experiments and their lungs exdsed. The pulmo- 
nary lobes were then separated from one another and the tumors on the surface of the lungs 
counted and measured as to diameter with a millimeter rule. No tumors measuring less than 
one-third ram. in diameter figure into the results. Intermittent microscopic sections controlled 
the findings. All were examined without knowledge of the group from which the individual 
~e. 
~va/uat/on of Re.~u/ts: 
In Vivo Exp~imen~s.--Mice of the various intrs-experimental groups were matched against 
one another in order of the numbers of tumors within each group that the individual animals 
developed and the response compared as to number of animals with tumors and number of 
tumors per individual, as is the standard  practice. The consistency and degree of response 
were thus measured. In addition, results of all experiments which showed differences were 
treated  statistically. In experiments in which equal numbers of mice survived in the com- 
pared groups, the probability of error was figured through the standard deviation of differences 
between matched pairs. In those experiments in which the numbers of animals were not equal 
the significance was calculated through the use of the "t"  test  (21).  Only the probability 
value indicating that the result obtained was not due to chance is recorded herein. Due to 
limitations in space, the results will be presented mainly in table form and the average number 
of tumors compared from group to group. The results of representative experiments will be 
shown in chart form in which the response of individual animals in terms of tumors will be 
represented by black or hatched columns which refer to the group within the experiment from 
which the ~nlmal came. The average size of tumors of the animals of the particular groups is 
also shown. The ;nhlbitory effect of an agent upon the number of tumors developing in an 
individual group was not considered significant if the average size of the tumors of the ex- 
perimental groups was different from controls by more than 0.05 ram. in diameter. This as- 
sumed range of normal deviation in average size was determined on the basis of deviations 
among groups of control animals killed after a  uniform interval and  taken  from many  ex- 
periments. When the number of tumors of the experimental groups exceeded the controls, 
and yet the average size of tumors in the experimental group was smaller this difference must 
be taken as evidence indicating that the increase in number occurred despite poorer condi- 282  URETHAIVE AND  ITS  MECHANISM  OF  ACTION 
TABLE i 
1 
2 
3 
4 
$ 
6 
7 
8 
t 
10 
11 
12 
13 
Test 
substance 
I  DNA 
DNA 
Amlnopterln 
Amlnopterin 
Amlnopterln ' 
Aminopterln 
2  Aminopterin 
AminopteHn 
Thymidyiic 
acid 
Thymidylic 
acid 
Utidyllc acid 
Uridylie acid 
Cytidyllc 
acid 
Mice used  Aver- 
Tu-  Total  Ade-  age 
Method  Started  Survived  raor-  ade-  no-  diam-  Statistical 
posi-  ross  eter  Effect  significance 
rive  no-  per  ade- 
"~  No.  Age  mice  mas mouse  nc- 
mas 
~ks.  [  ram. 
DNA/U  7 wks.--K  Sw  25  19  13  19  1  0.37  Inhlb- : p  =  <~0.01 
S/U  25  8-10  19  12  47  2.5  0.40  lied 
DNA-DNA/U  20  8  14  2  2  0.14  0.42  Inhlb. 
S-S/U  $ wks.--K  C  20  15  5  i0  0.66  0.48  ited  P  ~  <0.08 
I 
ALA-A-A~/U  7 wks.--K  Sw  20  9  8  48  5.3  0.44  In- 
S-S-S-S/U  20  8-10  20  12  47  2.4  0.40  creased 
Aa-A-A-As/U  25  8-10  $  I  5  77  15,4  0.52  In- 
S-S-S-S/U  8 wks.--K  Sw  25  19  18  139  7.3  0.52  creased 
ALA-A.At/U  25  14  44  2.7.  ~  0.45  In- 
S-S-S-S/U  8 wks.~K  $w  25  4  i0 [  12  27  1.4  0.$0  creased 
25  23  i  23  311  13.6  0,60  O* 
AS/Us/u  10 wks.~K  Sw  25  8  23  i  23  357  15.4  0,67 
I 
A-ALA-A-AVU  25  22  6  14  0.64  0.38  Inter- 
A-A~-A-A/DNAZ-A2/DNA/U  8 wks.~K  C  25  8  17  0  0  0.0  0  fer- 
S-S-S-S/s-S/s/U  25  19  3  4  0,22  0.64  ence  I 
At-A-&-A/U  25  3--4  19 ]  8  13  0.74  0.45  Inter- 
ALA,A/DNAS.A/DNA/U  8 wks.~K  C  25  20 i  7  9  0.46  0.42  fer- 
ence 
I 
20  i9[  16  79  4.15  0.50 
T~/U  8wks.~K  Sw  20  20[  i8  101  5.0  0.52  s/u  8  o 
I 
T4b/U  20  20  20  339  17  0.66 
S/U  12 wks.--K  Sw  4-5  ,  0  20  17 ]  i7  309  18  0.56 
I 
Ur~-UrSa/U  25  3  2t[  l0  12  0.57  0.65  O 
S-S/U  8 wks.--K  C  25  22  [  8  tO  0.46  0.50 
I 
Ur~-Ursa/U  25  22l  8  12  0.54  0.46 
S/U  7 wks.--K  C  4  0  25  21  6  i~  0,52  0.45 
C~/U  25  20  19  68  3.35  0.57  ~nhib-  P  ffi  <0.0~ 
S/U  8 wks.--K  Sw  25  5  21  i  17  126  6,0  0.55 
I  ited 
i  .... 
1  0.00025  m~. amlnopterin per gin. mouse i.p.  (0.0025  per cent)  *  These experiments were repeated 2-6  times, in  addition to the 
data shown, with the sarae general result. 
All solutions used except urethane were neutralized to  pH 6.5-7 
and raade isotonic with sodium chloride,  Those raark~i with a 
were not completely in solution but used as a suspension. 
Test agent/U, injections  given at same time. 
Test agent~test agent, 24 hour interval. 
K, killed. 
U, I rng. urethane (5 per cent) per gram mouse subcutaneously. 
S, volume of isotonic  sodium chloride equivalent to test agent 
i.p. 
DNA, I  rag. desoxyrlbonucleate (5 per cent) per gln.  mouse. 
This concentration  was found isotonic for  mouse red cells. 
solution amlnopterln in isotonic  salt). 
i  O.0QOS0 rag.  amiaopterln per gra.  mouse, i.p.  (0.0025  per cent 
solution aminopterin in isotonic salt). 
3 1 rag. desoxyribonucleate  (5 per cent) per gin. mouse sub- 
cutanenusly. 
4~  0.2  rag.  calcium thymidylate (i per cent) per gin.  mouse. 
4b  0.1 rag.  calclum thy'midylate (i per cent) per gln.  mouse. 
s~  0.I rag.  uridylic acid (2 per cent) per gin.  raouse. 
sb  0.2  rag.  uridyllc  acid (2 per cent) per gin.  raousc. 
0.I rag.  cytidyllc  acid (2 per cent) per gin.  mouse. STAN'FIELD  ROGERS 
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14 
15 
16 
17 
18 
19 
21 
22 
23 
24 
25 
26 
Test 
substance 
Cytidylic  C~/U 
acid  S/U 
3  Cytidylic  cSb-c/u 
acid  S-S/U 
Uridine-5-  UpT/U 
phosphate  S/U 
Desoxycyti-  Dcs/U 
dyilc acid  S/U 
Guanine  Gg"G/U 
S-S/U 
4  Adenine  Ad:o-Ad/U 
S-S/U 
4-amino-5- 
imidazole  4aU/U 
carbox-  S/U 
amide 
Method 
No.  Age 
wks. 
20 
7 wks.--K  C  20  4 
20 
7 wks.--K  C  20  4 
25 
9 wks.--K  A  25  5 
9 wks.--K  Sw  30  30  4 
9 wks.--K  Sw  25  25  8 
25 
7 wks.--K  Sw  25  3 
Mice used  Aver- 
Tu-  rotal  Ade-  age 
diatn-  Started  Survived  mor-  ade-  no-  Statistical 
pesi-  mas  eter  Effect  significance 
.~  rive  no-  per  ade- 
•  m&$  mice  mouse  no- 
mgs 
f~t~t. 
13  4  6  0.46  0.46  Inhib- 
14  6  11  0.8C  0.45  ited 
11  5  7  0.63  0.50  Inhib- 
15  I0  25  2.5C  0.44  ited 
24  15  31  1.3  0.54 
O*  24  14  29  1.2  0.63 
26  25  404  13.0  0.52 
O*  27  26  345  15.0  0.52 
O* 
21  14  55  2.62  0.40 
20  16  58  2.8C  0.38 
23  19  112  4.91  0.48  In- 
24  16  54  2.25  0.43  creased* 
P  --  <0.05 
P  •ffi  <0.01 
7 wks.--K  Sw  25  22  15  31  1.4  0.40  In. 
25  8  20  7  14  0.7  0.49  creased*  P  "  <0.01 
2-6-diamlno- 
purine 
Thymine 
5  Thymine 
uracil 
5-methyl- 
cytosine 
Cy~sine 
Cytosine 
2,6:~-2,6-2,6-2,6-2,6/U 
S-S-S-S-S/U 
30  21  11  16  0.76  0.50  O* 
8 wks.--K  C  30  3  26  13  17  0.65  0.40 
Thlt/U  7 wks.--K  Sw  70  3  49  23  56  1.1  0.40  Inhib- 
S/U  70  51  32  90  1.8  0.43  ited  P  ffi  <0.01 
Th:*/U 
Ua:VU 
s/u 
Inhib- 
30  27  19  60  2.2  0.50  ited  P  -  <0.01 
8 wks.--K  Sw  30  5  24  14  64  2.66  0.50  No sig. 
30  27  19  81  3.0  0.50 
dif.* 
MclS/U  25  24  10  26  1.1  0.50  DubI- 
S/U  8 wks.--K  Sw  4  ous  Not sig. 
25  25  16  38  1.6  0.48  dif.* 
CY:7/U  9 wks.--K  Sw  25  4  15  11  48  3.2  0.53  O 
S/U  25  19  14  63  3.3  0.57 
Cy:7/U  7 wks.--K  Sw  30  27  19  93  3.44  0.47 
O*  S/U  30  4  25  23  88  3.3~  0.40 
sb  0.2 rag.  cytidylic  acid (2 per cent) per gin.  mouse.  :s  0.1 mg.  2,6 diaminopurlne  (0.5 per cent) per gin. mouse. 
7 0.1 rag.  uridine-5-phosphate  (I per cent) per gln.  mouse,  is  0.2  rag. thymine~ (2 per cent) per gm. mouse. 
s  0.2 mg. desoxycytidylic acid (2 per cent) per gin. mouse.  :t 0.4 rag• thymine~  (2 per cent)  per gin. mouse. 
9  0.2 rag. guanine:~ (2 per cent)  per gin. mouse•  :s 0.4 rag. uracil1:(2 per cent)  per gin. mouse. 
10  0.2 rag. adenine:~ (2 per cent)  per gin. mouse,  te 0.4 rag. 5 methylcytosine  (2 per cent) per gin. mouse. 
zt 0.15  rag.  4-amino-5-imidazole  carboxamide  (0.75  per  cent)  per  ~7 0.4 rng. cytosine  (2 per cent) per gin. mouse. 
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TABLE I--Concluded 
27 
28 
29 
30 
31 
32 
35 
36 
37 
38 
39 
Test 
substance 
Omtic acid  O~*-O/U 
S-S/U 
Ol'-O/U 
Method 
60mtlc acid  S-S/U 
Olt/U-29 
O~U 
?  Orotlc acid  2  2  o=u 
4  2 
s/u 
2 
Dihydro-  Dn/O 
omtlc  acid  S/O 
Ureido- 
succlnic-  USa/U 
acid  S/U 
Ureido-suc-  Usa-Us/U 
cinJc acid  S-S/U 
I 
Mice used  Aver. I 
Tu-  Total  Ade-  age  I 
Started  Survived  mor-  ade-  no-  diam. P  Statistics] 
posi-no-  mas  eter  !  Effect  significance 
.~'  tire  mus  per  ade- 
No.  Age  mlce  mouse  no- 
mas 
wks.  ram. 
25  17  5  9  0.53  0.47  Inhib- 
8 wks.--K  C  25  7  21  10  20  0.91  0.52  ited*  P  =  <0.0~ 
13  0  0  0  Inhib-  7 wks.~K  C  25  7  0.40  P  =  ~0.0~ 
25  19  6  9  0.45  ited 
25  14  2  2  0.14  0.50 
25  19  4  7  0.37  0.69  I  Inhib- 
11  c  25  5  20  7  8  0.40  0.56  '  ited*  p  m  d0.0] 
25  21  8  11  0.52  0.57 
$wks.--K  Sw  25  5  21  9  17  0.8  0.52  Inhib- 
25  21  12  32  1.55  0.51  ited*  P  =  <0.05 
7 wks.--K  Sw  25  4  23  12  31  1.35  0.43  O 
25  22  11  29  1.32  0.37 
8 wks.--K  C  25 
25  4 
Dubi- 
22  6  7  0.33  0.50  ous 
18  7  12  0.66  0.46  inhibi-  Not sig. 
tion* 
Results of Experiments 33 and  34  are included  in the text. 
Aspam~dne 
Ast)artlc acid 
Urea 
Oxalo-acetic 
acid 
Na formate 
AsU/U 
S/U 
Ape/U 
S/U 
UOVU 
S/U 
OxS/U 
S/U 
FN/U 
S/U 
10 wks.--K  A  25  25  5 
8wks.--K  A  ~  5 
8 wks.--K  A  25  25  5 
8 wks.--K  Sw  25  25  4 
10 wks.--K  A  25  25  8 
21  18  53  2.5  0.57  Inhib- 
22  20  76  3.3  0.52  ited*  <P  -  0.05 
23  12  37  1.6  0.48 
O* 
24  14  30  1.25  0.54 
21  8  16  0.76  0.45  O* 
19  9  15  0.78  0.45 
13  9  49  3.77  0.62  In- 
16  14  31  1.93  0.70  :teased*  ~P  m  0.05 
22  21  81  3.7  0.561 
21  19  63  3.0  0.56  O* 
zs 0.1 rag. orotic acid~:  (1 per cent) per gin. mouse. 
110.075  rag. orotic acid  (0.25  per cent)  per gm. mouse. 
N 0.0375  rag. orotic acid (0.125  per cent)  per gin. mouse. 
0.0188  rag. orotic acid  (0.063  per cent)  per gin. mouse. 
u  0.1 rag. dihydrourotic  acid  (1 per cent)  per gin. mouse. 
u  0.2 rag. ureidosuccinic acid  (1 per cent)  per gin. mouse. 
t~ 0.3 nag. asparagine (3 per cent) per gm. mouse. 
Js 0.2 ms. uspartic acid (1 per cent) per gin. mouse. 
n  0.6 rag. urea  (2 per cent) per gin. mouse. 
0.5 rag. oxaloscetic acid (2.5 per cent) per Sin. mouse. 
n 0.4 rag. sedlum formate (2 per cent) per gm. mouse. STANFIELD ROGERS  285 
tions  for  growth.  The relation  between  the  size  and number of  tumors  of  various  sorts  and the 
conditions  of body growth have been well  shown by Tannenbaum  (14). 
The anesthetic effect of urethane can be taken as an indicator of the concentration and 
rate of metabolism of the agent (22). Some of the nucleic acid derivatives in high doses in- 
fluence the degree and duration of the anesthetic effect of urethane. Even though it had pre- 
viously been  found that the neoplastic response  of individual animals was related to the 
amount of urethane given rather than the peak concentration or duration of exposure  (12) 
the anesthetic influence of urethane on experimental and control groups was always noted. 
The dose levels of the derivatives of nucleic acid dealt with herein produced no differences 
between experimental and control groups in anesthetic effects. Another possible variable con- 
cerns the known correlation between growth rate of animals at the time of injection with 
urethane and their response in terms of tumors (12, 15"). It might be thought that the in- 
hibitory effects of some of these agents might be through a non-specific inhibition of growth 
rate at the time of injection with urethane. It has been demonstrated by Bullough (23) that 
the mitotic rates of various tissues, amongst them the skin, at a given time varies in the same 
direction though the individual tissue rates may be of a differing intensity, It seemed there- 
fore reasonable to use the mitotic rate in the .~Idn of individual animals as an index of the 
relative growth rate of their bodies at a given moment of time. All the substances found to 
reduce the number of tumors initiated by urethane were tested in this relation. Tests were 
made 5~ hours after injection of the individual substances in the same amount per gram used 
in these experiments. The number of mitoses occurring in 1 an. ear epithelium, an aggregate 
length made up of several 6 micron sections of the biopsy specimen, was taken as an index of 
the growth rate of the animal as a whole (23). Among groups of anlm~ds of ten mice each, 
matched as to weight, age, and sex, no decrease in mitotic rate in the ear epithelium was found 
on comparison of groups injected with the agents under test with animals receiving an equal 
volume of isotonic ~!ine. 
F,  xpcrlme~ in V~ro.--The t~hn;ques used in the experiments  in which the exposure of 
the lung tissue to the carcinogen was carried out in 1~/tyo  will be described in detail further on. 
Influence of DNA, Its Rate of Synthesis,  Certain of Its Constituents, and Certain 
of Tkeir Precursors upon tke Carcinogenic E:ffe~t of Uretkane 
Studies with radioactive isotopes have demonstrated that over 99 per cent 
of the urethane given in a  single dose of 1.5 nag. or less per gin.  mouse is ex- 
creted within 24 hours (24). Also it has been shown that lung tissue implanted 
24 hours after injection of the hosts with urethane develops no growths though 
exposure of mice to urethane  after implantation results in the occurrence of 
many tumors in the implanted tissue (25). The brief period of oncogenic ac- 
tivity of urethane injected in a  single dose in an amount which readily produces 
lung tumors (26) would appear to provide opportunity to test whether various 
metabolites or substances would modify its oncogenic effectiveness. If so they 
might  interfere at certain known metabolic loci and thereby cast light  upon 
the mechanism of the carcinogenic action of urethane. 
Findings  in Experiments  1 througk 30  (Table I, Ckarts  1 through 8).--The 
substances  tested  are listed  in Table I  in the general  order of  the  size and 
complexity of their  molecules and  in  relation to  their  estimated  position  in 
the  pathway  of  nucleic  acid  synthesis.  The  experiments  were  done  in  this 
order and  the methods used  were essentially identical in them  all. The dose 286  URETHANE  AN~  ITS  ~ECHANISM  OF  ACTION 
levels chosen were, with  the exception of aminopterin,  well  within the level 
tolerated by the animals.  Because of this similarity it has  seemed sufficient 
to outline the individual experiments in table form rather than  describe each 
in detail. 
All the pertinent data are included in Table I  except the relative responsiveness of the 
individual animals. This is shown in representative accompanying  charts (1 through 8). No 
test substance was given after injection of the animals with urethane because only the initia- 
tory phase of carcinogenesis  was  to be studied (24, 12, 25). The experimental and control 
animals were similarly  maintained after injection to insure that the subsequent growth of the 
neoplasms would take place under the same conditions. The facts sought are concerned  with 
direction  of effect rather than quantitative comparison and only such trends will be noted 
in the text description. 
In Experiments 1 and 2 (Table I, Chart 1) it is evident that the DNA hy- 
drolysate had a profound inhibitory influence upon the carcinogenic activity of 
urethane. The weight curve of the individual animals of Experiment 1 (Chart 1) 
makes clear that the brief exposure to this dose of the DNA hydrolysate was 
without manifest non-specific toxic effect which might have influenced the rate 
of growth of the neoplasms and henceforth their manifest number. The number 
of  tumors in the DNA-treated animals was too few to allow their size to be 
taken as a measure of relative growth rate in these experiments. 
Nucleic acid hydrolysates are well known to have a  broad spectrum of bio- 
logical activities  not  necessarily related  to  nucleic acid  metabolism.  Conse- 
quently, aminopterin,  which inhibks  desoxynucleic acid synthesis,  was  used 
in an attempt to clarify to some extent the meaning of the DNA inhibition. 
Several days of treatment of mice with anduopterin are necessary for inhibition 
of nucleic acid synthesis at dose levels which allow survival of a  considerable 
proportion of the animals (17). In Experiments 3, 4, 5, 7, and 8, this procedure 
was  carried out. Death of so large a proportion of animals (Table I) seemed an 
indication that enough of the antagonist was being given to have the desired 
effect.  However,  too  few  animals  survived  the  aminopterin  treatment  for 
proper statistical  study of individual experiments; in  consequence, repeated 
experiments were necessary. Despite the fact that the animals were sickly for 
almost a week after aminopterin and urethane treatment, it is evident that the 
pretreatment with aminopterin resulted in an increase in adenomas  brought 
about by urethane injection. Comparison of the average size of tumors in the 
various experimental and control groups indicates that this increase in tumors 
occurred despite the fact that the tumors were growing less well and,  accord- 
ingly, fewer would have a chance to reach a discernible size in the time interval 
allowed. In contrast to the potentiating effect of aminopterin when given under 
conditions known to inhibit DNA synthesis (17), no effect, except a slight reduc- 
tion in the number of tumors appearing, was seen when only immediate pretreat- 
ment with this agent was used (Experiment 6, Table I). Such a short treatment STAN'~IELD ROGERS  287 
schedule with aminopterin at this dose level has been found to exert no influ- 
ence on nucleic acid  synthesis (17).  The  slight  reduction  in  the  number  of 
tumors  in this  experiment  could be accounted for by the reduction in their 
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CHART 1.  The inhibitory influence of injection of a DNA hydrolysate upon the initiation 
of adenomas by exposure of mice to urethane. (Experiment 1). 
growth rate because of non-specific  toxic effects of the drug. That the growth 
rate of the tumors of the aminopterin-treated mice was less than controls was 
indicated by the smaller average size of adenomas in the experimental group. 
Iris possible that the influences of aminopterin upon the carcinogenic activity 
of urethane might be through mechanisms other than through the effect upon 288  URETHANE  AND  ITS  MECHANISM  OF  ACTION 
nucleic  acid  synthesis. 1  Consequently,  an  attempt  was  made  to  determine 
whether  the  DNA  hydrolysate  might  eliminate  the  aminopterin  effect.  In 
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CH~T 2. The potentiating effect of pretreatment of an|m,ls with ~m!nopterin upon the 
J~tiation of adenomas by exposure of mice to ureth-~e and its blockage by injection  of a 
DNA hydrolysate. (Experiment 7). 
Experiments  7 and 8  (Table I  and  Chart 2) it is clear that  injection  of DNA 
into  mice pretreated  with  aminopterin  greatly  reduces  the  adenomatous  re- 
1 Unpublished  experiments  have indicated  that  the aminopterin effect is not mediated 
through its side action on the choline-methionlne  system which results in fatty livers (See 
Petering,  PkNsiol. Rev., 1952, 82, 197). Deficiencies in the same pathway can be produced 
by starvation and the resulting  fatty livers can be prevented by methionlne.  Methionine, STAN'~IELD ROGERS  ....  289 
sponse  of the mice to urethane. Hence, it seemed more likly that the inter- 
ference of initiation of adenomas with urethane by DNA was metabolically 
specific. 
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CH~T 3.  The  inhibitory influence  of  cytidyllc acid.  (Experiment 15). 
For this reason, various constituents of nucleic acid were put to test. Of the 
pyrimidine nucleotides tested (Experiments 9 through 17)  only cytidylic acid 
yielded any effect upon the response in terms of number of tumors brought 
about by urethane (Experiments 13 to 15, Chart 3). Like DNA, cytidylic acid 
rather than exerting an inhibitory influence on urethane carcinogenesis in fasted ~mA!s as 
would be expected  should ~m~opterin be exerting its influence  through producing fatty 
livers, actually greatly increases  the number of adenomas initiated. 290  ~~  ANY ITS ~[E~SM  o~  ACTION 
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CHART 4.  The  potentiating influence  of adenine,  (Experiment  19). STANFIELD  ROGERS  291 
reduced the number of adenomas initiated. Two dimensional paper chromtog-a 
raphy of the cytidylic acid in a butanol:urea and an isoamyl alcohol: phosphate 
solvent (27)  showed only one substance, that  at the Rf of cytidylic acid. 
Because of the results with adenine (Experiment 19, Chart 4) which increased 
the carcinogenic  effect of urethane  the various purine  nucleotides were not 
examined. 4-amino-S-imidazolecarboxamide,  a  precursor to adenine  (28) also 
potentiated the carcinogenic  effect of urethane (Experiment 20).  Guanine was 
without effect,  but, in view of its extremely low solubility, little significance 
can be attached to this result.  2,6-diaminopurine  which interferes in purine 
synthesis and influences the lethal effects of urethane in bacterial systems (29) 
proved without influence  upon the carcinogenic  activity of urethane (Experi- 
ment 21). 
Among the pyrimidine bases only thymine reduced the number of adenomas 
produced by the single exposure of animals to urethane (Experiments 22  and 
23). Uracil, cytosine, and S-methyl cytosine were ineffective in the dose range 
tested (Experiments 23 to 26).  The average size of adenomas in animals re- 
ceiving the single  dose of thymine prior to urethane was so close to that  of 
the control groups that it was clear that no non-specific toxic effect mediated 
the reduction  in  the  number  of tumors in  the  thymine-treated  animals  by 
influencing  their growth. The lack of any such toxic effect was also confirmed 
by the weight curves (Chart 5). 
The activity of thymine made it appear worthwhile to find whether the pre- 
cursors to the pyrimidines might influence the carcinogenic  activity of urethane. 
For this reason, studies were made of the action of orotic acid (30, 31).  The 
results of Experiments 27 to 29,  (Table I  and  Chart 6) made p]ain that not 
only did orotic acid profoundly modify the responsiveness  of the animals  to 
urethane but that upon varying the dose of either urethane  (Experiments 27 
and  28)  or orotic acid  (Experiment  29)  the two substances acted much like 
competitive antagonists  of one another.  In Experiment  29, all animals  were 
fasted 24 hours prior to exposure,  to eliminate dietary pyrimidines.  Experi- 
ments with dihydro-orotic acid (Experiment 30),  the precursor to orotic acid, 
(32,  18), also revealed an inhibition of the carcinogenic  activity of urethane. 
Ureidosuccinic acid, a  metabolic precursor of dihydro-orotic acid (32) on the 
other hand, had no significant  activity at the dose level used (Experiments 31 
and  32,  Table  I).  It seems quite possible,  however, that  it may have been 
metabolized before the exposure of the mice to urethane had elicited the carcino- 
genic substance responsible for the initiation of the pulmonary tumors (19), 
since it has been demonstrated that urethane itself is not the immediate car- 
cinogen  for the pulmonary  cells  but rather  elicits  or is transformed  to  the 
carcinogen after injection in the several species tested (19). This seems the more 
likely in view of the results of in dtro studies which follow. 
It seemed possible that the metabolic effect produced by the intermediary ADENOMAS 
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CHART 5.  The inhibitory  influence of thymine and the absence of effect of uracil when given 
immediately prior to injection of animals with urethane.  (Experiment 23). 
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carcinogen might be modified through the use of additional substances, should 
the reaction occur with sufficient rapidity and in an in vitro system rather than 
after  implantation of  the  exposed  tissues. 
General  Metkod in Vitro  Experiments.q 
Rabbits are among the species  which, following  injection with urethane, produce a carcino- 
genic intermediate acting on the pulmonary cells (19). Serum from this species taken 5 hours 
after intraperitoneal injection of the animals with 1.5 rag. urethane per gin. rabbit was used 
to supply the in v~ro carcinogen as in previous experiments (19). Mouse lung tissue was ob- 
tained from feta  mice late in gestation by the methods described by Rous and Smith (33) 
or from neonatal snimMs. Precautions for asepsis were used throughout. The lung tissue was 
hashed into tiny fragments between knife blades while suspended in Ringer's solution, then 
was separated, and divided into the number of lots necessary for the individual  experiments. 
Each lot was suspended in the intermediate containing  rabbit serum with and without addi- 
tion of the metabolite under test in each experiment. Exposure was at 37°C. for the period 
indicated.  Following exposure, the lung fragments  were transferred  to Ringer's solution, 
rinsed with 10 cc. and resuspended in fresh Ringer's. These suspensions were then implanted 
in the posterior thigh muscles of mice of the same strain as that supplying the tissue. In all 
instances material from the experimental and control groups were implanted in opposite legs 
of the same host. After an interval of 8 weeks the implants were excised and examined for 
tumors in serial section. 
In the evaluation of the results it is evident that, since what is being compared is the rela- 
tive response of the lung tissue exposed to the carcinogen in ~itro, the volume of tissue sur- 
viving, l~ther than the number of mice implanted, is the critical factor. The amount of tissue 
surviving was determined histolosically, all the tissue being cut serially at 6 ~ and the ag- 
gregate amount of lung tissue measured exclusive of extraneous tissue and cysts. In studies 
involving  a similar in ~#o method but with ultraviolet radiation (34, 35) or nitrogen mustard 
(36) as the carcinogen all trends yet found have proved reproducible with every attempt. 
Nevertheless a 100 per cent difference  in the response of compared tissues is used as indicating 
a significant difference. Only the results of the in vRro tests made with urcidosuccinic add and 
in a single instance with uridine-S-phosphate will be reported at this time. 
Experlm~t 33.--The lungs from 12 one week old "A" mice were excised and hashed into 
small pieces as described above and divided into three parts.  One part was added to 1 cc. 
posturethane  rabbit serum--Ringer's  mixture (0.9 cc. serum and 0.1 cc. Ringer's); one part 
to a mixture containing  0.9 cc. serum plus 0.1 cc. 2 per cent ureidosuccinic acid at pH 7; and 
the remaining part was added to 0.9 cc. serum containing  0.i cc. 2 per cent uridine-5-phosphate 
at pH 7. All were exposed simultaneously with intermittent agitation for 1 hour at 37-38°C. 
in a water bath. Afterwards the exposed tissues of each lot were washed with 10 ec. and fol- 
lowed by 5 cc. of Ringer's solution. Each was suspended in 2 cc. Ringer's and imp]anted in 
0.2 cc. amounts in alternately opposite posterior thighs of 15 normal young adult "A" str~Jn 
mice. After an interval of 2 months the hosts were killed, and the implants were excised and 
examined in serial section for adenomas. 
The tissue exposed in this experiment to carcinogenic serum plus Ringer's 
yielded five adenomas; that exposed to the same serum containing uridine-5- 
phosphate yielded three adenomas. None were found in the tissues exposed to 
the same carcinogenic serum but containing 0.2 per cent ureidosuccinlc acid. 
The tumors were scattered singly among the 30 implants of the 15 hosts used. STANlqELD ROGERS  295 
No difference  was noticeable  in the relative  amount of surviving lung tissue 
from the three exposed lots. 
The inhibitory influence  of ureidosuccinic  acid upon the carcinogenic  effect 
of the urethane intermediate was confirmed  in the following experiment: 
Exp.'ins'hi 34.--This  experiment was  similar to  Experiment 33  with  the following ex- 
ceptions: only ureidosuccinic acid was tested; the final concentration used was 0.I per cent; 
20 "A" strain fetuses from three pregnant does ]ate in gestation supplied the lung tissue under 
test; and 18 normal young adult "A" mice were recipients of the tissue. Agai  n  the implants 
were examined 2 months after exposure and implantation. 
The tissue exposed to the seruin-Ringer's mixture developed five adenomas. 
That  exposed to the semm-ureidosuccinic acid mixture  developed only  one. 
Except in one instance in which one implant  had two tumors the adenomas 
were scattered singly among the 36 implants carried by the 18 hosts. No differ- 
ences were noted in the amounts or general character of the implanted  tissue 
when compared microscopically. 
Uridine-5-phosphate has not been subsequently tested at this writing. 
Studies with Small Molecular Precursors 
Since urethane itself is not the immediate carcinogen for the lung but rather 
elicits or is transformed into the active carcinogen (19) it seemed worthwhile 
to find if anyof the smallmolecules constituting basic building blocks of nucleic 
acid would influence  its carcinogenic  activity. Aspartie  acid (18),  urea  (18), 
oxaloacetic acid (18), and formate (17, 16) appear to be among the more im- 
portant of tlfese. Only the results of representative experiments are shown in 
Table I, Experiments 36 to 39. Aspartic acid, urea, and formate were without 
any detectable effect upon the number of tumors initiated.  Oxaloacetic acid, 
however, considerably increased the number of tumors appearing. This finding 
was repeatedin three additional experiments. As oxaloacetic acM is chemically 
highly reactive, it seemed possible that urethane might be combining directly 
with it.  Experiments in which the oxaloacetic acid and urethane were mixed, 
incubated at 37°C. for 2 hours and then injected together,  showed no greater 
activity to induce tumors than when the two substances were injected sepa- 
rately. The results of these experiments are not shown in the table. 
In view of the inactivity of aspartic acid, tests were made with asparagine 
as this might be a more active form in the pathway of synthesis of ureidosuccinic 
and orotic acid. Upon testing,  asparagine was found to distinctly inhibit the 
carcinogenic  activity of injected urethane  (Experiment 37). 
Negative Results  witk Metabolically Active Substances Which in Full-Fed Mice 
Are Unrelated to DNA Synthesis  (Experiments 40 tkrough 49, Table II) 
In the evaluation of the specificity of any series of tests such as the above 
described the possibility that similar  effects might Occur with a grea  t  variety TABLE H 
The lack of effect of a  variety of metabolically active substances  not closely related to 
nucleic acid synthesis upon urethane carcinogenesis. The substances tested were injected in 
each instance immediately prior to urethane. The method of test is identical with that used 
in the experiments listed in Table I. 
Experiment  Test substance  Adenomals  per mom~ 
40  Glutathione 
41 
42 
43 
44 
45 
46 
47 
48 
49 
BAL 
Glutamic acid 
Methionine 
Cysteine 
E~o~e 
Folic acid 
Acriflavin 
Nitrogen mustard 
Para-aminobcnzoic acid 
Method  Sur~.'ving 
mice 
Glul/U  25 
s/u  25 
BAL~/U  18 
S/U  18 
GAS/U  18 
S/U  19 
M4/U  28 
S/U  34 
CyS/U  23 
S/U  20 
~'.°/U  15 
S/U  19 
FT/U  24 
S/U  23 
AcS/U  22 
S/U  23 
NHm/U  21 
S/U  24 
Pbg/U  16 
S/U  16 
14 
14 
2 
2.4 
2.5 
2.9 
1.2 
1.3 
0.56 
0.68 
3.5 
3.2 
0.5 
0.5 
2.1 
2.0 
13 
10 
The /  line separating the test substance from urethane indicates the test substance was 
given immediately prior to ureth~ne injection. 
The test substance was given intraperitoneaUy in the amount indicated immediately prior 
to subcutaneous injection of 1 rag. urethane per gin. mouse used as a  5 per cent solution in 
double distilled water. 
The amount of the test substances used are as follows.  ~--- 
1 Glutathione, 1.3 reg./gin, mouse. 
British antileniclte, 0.012 reg./gin, mouse. 
a Glutamic acid, I reg./gin, mouse. 
4 Methionine, 1 reg./gin, mouse. 
s Cysteine, 0.9 gm./gm, mouse. 
s Ethionine, 0.5 reg./gin, mouse. 
7 Folic acid, 0.05 reg./gin, mouse. 
s Acriflavin, 0.025  reg./gin, mouse. 
9 Para-aminobenzoic acid, 0.06 mg./gm, mouse. 
m Nitrogen mustard, 0.001 reg./gin, mouse. 
All solutions were isotonic and neutralized to pH 7. 
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of metabolic substances is obvious. In studies directed toward finding  other 
intermediary  pathways influencing  the activity of injected urethane,  wholly 
negative results have so far been obtained.  The method of test was similar 
to that of the preceding in ~i~o experiments. The individual substances tested 
include those listed in Table II. In this table the substance used, the amount 
given, the number of surviving mice, and the average number of tumors in the 
experimental and control groups are shown, All were used in amounts approach- 
ing the amount maximally tolerated by mice. In none of these instances was a 
significant  influence  demonstrated. Other substances which have proved with- 
out effect, but which have only been tested on one occasion, include potassium 
cyanate,  choline,  and  histidine. 
DISCUSSION 
The fact is clear that the exposure of mice to nucleic acid hydrolysates, cer- 
tain of the components of nucleic acid, and substances influencing nucleic add 
synthesis, such as aminoptedn and pyrimid~ne  and purine precursors, simul- 
taneonsly with urethane profoundly modifies the effectiveness of the carcinogen. 
The absence of effect of biologically  active substances not particularly related 
to nucleic acid synthesis (Table II) speaks for the general chemical  spedficity 
of the results. In view of our limited knowledge of nucleic acids and their synthe- 
sis, the crudeness of the test methods, and the complexities of the problem under 
study it is not possible to interpret the meaning of the results except in a very 
general way. However, when the experimental findings  are examined in rela- 
tionship to one another and in relation to known facts concerning  the inter- 
mediary metabolism of nucleic acid it would appear that certain definitive con- 
clusions may be drawn. 
The  profound inhibition  of the initiation  of adenomas  effected by simul- 
taneous  injection of DNA with  urethane  is striking  (Experiments  1  and  2, 
Chart  1).  An almost equal inhibitory influence  was obtained in preliminary 
experiments not included in this report when an RNA hydrolysate was used 
with urethane. In contrast to DNA however the injection of the ribosenucleic 
acid hydrolysate made the animals ill for the 1st week and the reduction in 
number of tumors could be ascribed in considerable degree to an over-all in- 
fluence on the health of the animals and reduced growth of the tumors (14). 
Because of this  RNA hydrolysates were not  subsequently used though  the 
components of RNA like DNA were tested in the experiments which followed. 
As the effects of either of these substances might be through mechanisms other 
than an influence upon nucleic acid synthesis, the results of the experiments in 
which animals were pretreated with aminopterin under conditions known to 
inhibit nucleic acid synthesis (17)  (Experiments 3 to 5) are particularly per- 
tinent. The potentiation of the carcinogenic  effect of urethane occurred despite 
the fact that the aminopterin  treated animals did poorly, as shown by their 298  IYI~TIIAN'E AND  ITS  M3~CIIANIB~  OF  ACTION" 
weight curves (Chart 2), and that their adenomas grew at a slower rate (Table 
I). Both these conditions alone would yield results tending toward an over-all 
reduction in number of tumors (14). The lack of any effect of aminopterin when 
given over too short a period to influence  nucleic  acid synthesis by the time 
of urethane  injection  (17)  and  the  prevention  of the potentiating  effect of 
aminopterin  by injection of the animals  with DNA  (Experiments  7 and  8) 
(Chart  2) provide evidence pointing toward the chemical specificity of both 
aminopterin and DNA. Biologic parallels  to the prevention of an aminopterin 
effect  with  DNA  have  been  demonstrated  both  in  the  reversal  of  the 
aminopterin inhibition of growth in the chick embryo by DNA (38) and in the 
dilution  of  the  incorporation  of isotopically tagged  formate  into  DNA  by 
thymidine,  a  path  of synthesis known  to  be blocked by aminopterin  (39). 
That  there  is a  relationship  between the synthesis of nucleic  acid  and  the 
mechanism  of  carcinogenesis  brought  about  through  exposure  of  mice  to 
urethane seems clear. The results of Experiments 9 to 39, in which the various 
components of both DNA and RNA were put to test add weight to this  con- 
clusion. 
The interpretation of the results of the experiments in which various nucleic 
acid components and precursors were used is conditioned by the methods of 
testing  and  by many important  variables.  A  foremost possibility relates  to 
whether the action of various metabolites tested is at the level of formation 
of the carcinogenically  active intermediate derived from or elicited by urethane 
(19) or at the level of the action of the carcinogen  upon the pulmonary cells. 
Since ureidosuccinic  acid (Experiments 33 and 34) was demonstrated to have 
in vitro influences upon the carcinogenic  effect of the active intermediary sub- 
stance,  it appears  that  this  substance at least and,  in all probability, other 
more fully formed components of nucleic  acid  exert  their  influences  at  the 
level of the pulmonary cells.  Another  possibility relates  to whether  the  in- 
hibitory action of any of these substances is simply related to an over-all inhibi- 
tion of growth or whether they produce their effect without influencing  the 
growth rate of the animals.  As described none  of the substances, which when 
given with urethane resulted in a reduction in the number of tumors initiated, 
were found to reduce the mitotic rate of ear epithelium of animals injected with 
similar amounts of these substances and biopsied 5 hours later.  It is evident 
that the possible activity of any of these agents depends upon its being present 
at the level of the pulmonary  ceils in the proper  concentration  and  at  the 
proper time to block or by-pass any interference or imbalance in the synthetic 
chain set off by the carcinogen.  Many of these molecules are degraded at rapid 
rates  (37).  For these reasons the negative experiments in vivo cannot be re- 
garded in any sense as conclusive tests. This is particularly pertinent in relation 
to the activity or lack of activity of the nucleotides tested. Though thymidylic 
acid (40), uridylic acid (41), cytidylic acid (42), desoxycytidylic acid (43), and STANlVIELD  ROGERS  299 
uridine-5-phosphate (44) have all been shown to be incorporated into the DNA 
of mammals upon injection, only cytidylic acid (Experiments 13 to 15, Chart 3 
exerted any in vivo influence upon the effectiveness of the carcinogen. On the 
other hand ureidosuccinic acid, inactive in vi~o, exerted an inhibitory action in 
the in vitro tests (Experiments 33 and 34). The in vi~o effect of cytidylic acid 
proved of special interest in view of the opposite and potentiating influence of 
adenine (Experiment 19) and its precursor, 4-amino-5-imidazole  carboxamide 
(28) (Experiment 20), upon the carcinogenic activity of urethane. This is par- 
ticularly  the: case  since  an  antagonism  hasbeen  demonstrated  between 
adenosine and cytidine in mutant strains of Neurospora  (45). It is noteworthy 
that isotopically labelled  cytidylic acid contributes both to RNA and DNA 
pyrimidines  (46).  That  desoxycytidylic acid  was  without  effect upon  the 
adenomatous  response is perhaps a parallel to its lack of activity in diluting the 
incorporation of desoxyuridine into  thymidine in  bone  marrow or Ehflich 
ascites tumor cell systems (40). Bearing ~s well on these other negative tests 
there is considerable  reason to believe that there is a  large variation in the 
uptake of individual nucleic acid components by somatic cells of different sorts 
(37). The disparity however in the results obtained with these mononucleotides 
as compared with the tetranucleotide exposure (DNA) is striking and suggests 
that  certain nucleotide combinations arising  from the in  vi~o, presumably 
enzymatic (46), hydrolysis of the tetranucleotides might!account for the pro- 
found inhibitory effect of DNA. 
Because of: the potentiating effect of adenine and the absence of effect of 
2,6-diamino purine (Experiment 21) when given under .conditions  known to 
interfere in purine synthesis (47), the purine nucleotides were not tested. 
Among thepyrimidine bases the activity of thymine (Experiments 22 and 23, 
Chart 5) was striking. This result seems the more important since the thymine 
used was prepared synthetically rather than derived from nucleic acid and, 
hence, could not possibly be contaminated with other nucleic acid components 
which could conceivably be present in small amounts in pyrimidine bases and 
in nucleotides of natural origin.  It seems particularly significant  that of the 
pyrimidines only thymine has been shown to be incorporated specifically into 
DNA (46) Uracil, on the other hand, known to be incorporated into RNA 
(37, 46)  exerted no influence on the carcinogenic  actions of urethane. It has 
also been demonstrated by Fink and Fink (48) that supplementary thymine 
diminishes the incidence of spontaneous pulmonary adenomas in mice. It is 
perhaps noteworthy that cytosines 5-methyl equivalent to thymine, 5-methyl 
cytosine, exerted an inhibitory influence  in the same direction  as thymine. 
Though this difference (Experiment 24) did not prove statistically significant 
under the method of test it is considered to indicate a trend and fits with the 
fact that thymine is one of the degradation products (37) of 5-methyl-cytosine. 3OO  URETHANE AND ITS MECHANISM Ol~ ACTION 
The inhibitory action of thymine raised the possibility that the primary site of 
action of the carcinogen might be at the level of the pyrimidine precursors. 
Of the various precursors  and components of nucleic acid which have been 
traced by isotopic technics into the formed nucleic acid molecule, orotic acid 
has proved to be one of the substances  most effectively and universally in- 
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CHART 7. The inhibitory influence  of orotic acid and its increasing effectiveness  in this 
respect as larger amounts are used in fasted  animals receiving  constant amounts  of ure~hAne. 
(Experiment 29). 
corporated in nucleic acid synthesis. It has been found exclusively in the pyrimi- 
dines. The studies describing these findings have been recently reviewed (37). 
It appears of special importance therefore that, of the various agents tested for 
influence upon urethane carcinogenesis, orotic acid proved by far the most 
active in vi~o inhibitor (Experiments  27 to 29). That its action is suggestive of 
competitive inhibition may prove especially pertinent (Experiments 28 and 29, 
Charts 6 and 7).  Nevertheless,  the inhibitory activity of dihydro-orotic acid 
(Experiment 30) suggests that the point of interference  of the carcinogen lies 
among the precursors  of orotic acid since dihydro-orotic acid is its precursor STANlCIELD ROGERS  301 
(32,  18). The inhibition of the in dtro activity of the carcinogen by ureido- 
sucdnic acid,  the precursor to dihydro-orotic acid (32),  adds further weight 
to this view (Experiments 33 and 34). With ureidosuccinic acid it is plain that 
the time of exposure and perhaps the concentration play a critical role in the 
action of metabolites upon the carcinogenic process, it having no effect in vi¢o 
(Experiments 31 and 32) and yet distinct in vitro inhibitory influences (Experi- 
ments 33 and 34). In addition, it must be pointed out that, despite our knowl- 
edge of the incorporation of ureidosuccinic acid into nucleic acid pyrimidines 
in ~ro, it has yet to be shown that when injected into intact animals this 
substance enters into the pathway of nucleic acid synthesis (46). Although its 
in vilro inhibitory activity (Experiments33 and 34) does not necessarily indicate 
that its immediate action under the conditions of test were mediated through 
its relation to nucleic add, this interpretation seems the more likely in view 
of the other findings. That an effect was brought about at all indicates that 
part of the metabolic sequence of carcinogenesis may be studied through these 
in  vitro means. 
The significance of the gn vitro activity of ureidosuccinic acid has perhaps 
more specific relations. Among the foremost  of these is its remarkable similarity 
in molecular structure to urethane: 
Ureidosuccinic  acid 
COOH 
I 
HC--NH~C--NH,  HC--0--C--NII, 
1  11  I  II 
HCH  0  HCH  0 
I  I 
C00H  H 
Urethsne 
This similarity has further interest when it is considered that oxaloacetic 
acid which has been shown to be a precursor to ureidosuccinic  acid (18) po- 
tentiates the in vi~o carcinogenic  activity of urethane (Experiment 38).  The 
wen  known  interrelation  between  oxaloacetic  add,  aspartic  acid,  Krebs's 
cycle, and the incorporation of the carbamyl group of citrulline into pyrimidines 
through ureidosuccinic  acid appears pertinent  (see review,  reference 37)  to 
the interpretation of this result. This is particularly the case since an inter- 
mediary substance, and not urethane itself,  is the active carcinogen at  the 
level of the lung (19).  Might urethane, for example, be interfering with or 
O 
II 
diluting the utilization of carbamyl groups (NHr-~--R) in the synthesis of 
ureidosuccinic acid and thereby producing the carcinogenic intermediate inter- 
feting in the synthesis of nucleic acid pyrimidines? The evidence in this report 
is consistent with such a  view. 302  URETHANE  AND  ITS MECHANISM  0~' ACTION 
When taken in relation to one another the above facts make it evident that 
the mechanism of action of urethane in initiating these pulmonary tumors is 
closely associated with nucleic acid synthesis. Whether RNA or DNA is par- 
ticularly involved is however much less dear. The potentiating or inhibitory 
activities of the various substances used are all consistent with an influence 
on DNA synthesis. This, however, is not the case for RNA. Aminopterin~  for 
example,  is known to interfere in both adenine and thymine synthesis (46). 
As  adenine  itself  markedly  potentiates  the  carcinogenic  effect of urethane 
(Experiment  19,  Chart  4)  an interference in its synthesis would scarcely be 
expected to also potentiate, as was the effect produced by aminopterin  (Ex- 
periments 3, 4, 5, 7, and 8). As it is through an interference in the production 
of adenine that aminopterin interferes in RNA synthesis (37) one would con- 
clude that an effect on RNA is not the influence  of urethane which is being 
inhibited by components of the injected DNA hydrolysate (Experiments 1, 21 
7, and 8). It is then much more likely that the effect of aminoptefin on urethane 
carcinogenesis  is  through  its interference  in  the  synthesis of thymine.  The 
inhibitory activity of thymine itself (Experiments 22 and 23) is also inconsistent 
with an influence  of urethane on RNA as thymine has been found by isotope 
tracer methods to be incorporated specifically  in DNA and not degraded or 
modified in a way so as to become part of RNA (46). The lack of effect of uracil, 
when like thymine given only at the time of urethane injection (Experiment 23) 
adds further  weight to the view that  the influence  of urethane  is on DNA 
synthesis for uracil is known to be incorporated into RNA upon injection but 
not DNA  (46).  Moreover (in  preliminary  experiments not included herein) 
when uracil is given the day prior to urethane as weU as at the same time and 
thus has an opportunity to be degraded or modified and used in resynthesis of 
other  nucleic acid  pyrimidines  (37)  it has  an  inhibitory  influence.  The po- 
tentiating  effect of aminopterin  seems best  explained  by a  decrease in  the 
&  ~vo  synthesis of DNA thymine produced by aminopterin and a consequent 
increase in uptake of exogenously provided thymine and perhaps thymine-like 
substances. Such effects are weU known in experiments in which isotopically 
tagged purines are used (49).  On the basis of these findings  it would appear 
likely that the action of urethane is related to DNA rather than RNA synthesis. 
But what sort of an effect is the carcinogen exerting.  Conceivably the carcinogen 
could be an atypical pyrimidine ultimately incorporated in nucleic acid and 
henceforth resynthesized and passed along from cell to cell. On the other hand, 
its action could be merely the result of temporary interference in the synthesis 
of certain nucleic acid components, the latter possibly ultimately modifying the 
final structure of the nucleic acid molecule through a change in distribution of 
components at the time of synthesis. As pointed out above, the potentiation of 
urethane  carcinogenesis  by aminopterin  (Experiments 3  to 5)  could be con- 
sidered a  result of a  diminution  in the diluting  effect of otherwise normally STAN'FIELD  ROGERS  30~ 
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synthesized thymine (39, 37)  upon  the  incorporation of any new atypical 
pyrimidine into the DNA of the cells undergoing neoplastic change. This is 
perhaps the case also  with adenine (Experiment 21)  a  known antagonist of 
cytidylic acid--a precursor of DNA thymine (46)  (Chart  8).  Furthermore, if 
the carcinogenic effect  were simply a non-specific reduction of available thymine 
at the time of synthesis of DNA, one might expect aminopterin itself to be 
carcinogenic.  This has not been the case in repeated experiments (from un- 
published data). On the other hand, injections of mice with a  hydrolysate of 
adenoma DNA yielded no tumors in a single test. However, if this postulated 
atypical pyrimidine is synthesized within the pulmonary cell---as would seem 
likely to be the case because of the in vitro inhibitory effect of ureidosuccinic 
acid (Experiments 33 and 34)--it might be that following in vivo injection, the 
atypical  pyrimidine  is  degraded  before  reaching  the  lung.  That  certain 
pyrimidines are rapidly degraded is well established (37). Future in tgtro tests 
may cast light on this point. Whatever the fact may be it is evident that the 
sequence of biochemical syntheses in the pathway to the ultimate carcinogenic 
effect may be blocked or diluted by substances active at the respective levels 
in nucleic acid synthesis of ureidosuccinic acid, dihydro-orotic acid, orotic acid, 
cytidylic acid, and at the level of synthesis of DNA thymine (Chart 8). Though 
it seems likely that the carcinogenic influence of urethane is exerted through 
modifying DNA rather than RNA synthesis, lack of evidence as to the specific 
relation at this time precludes anything other than the suggestion that the 
ultimate carcinogenic  effect is  nuclear. Nevertheless, this view is  consistent 
with facts previously reported concerning the initiation of pulmonary adenomas 
with ultraviolet radiation (34, 35) and nitrogen mustard (36). 
SUMM  ~RY 
The process  of carcinogenesis  following  exposure of mice to  urethane is 
demonstrated in the present work to be intimatelyrelated  to nucleic acid synthe- 
sis. Injection of animals with a DNA hydrolysate immediately prior to a single 
exposure of the animals to urethane markedly  reduced the number of pulmonary 
adenomas initiated. Amluopterin, known to interfere in nucleic acid synthesis 
(46), potentiated the carcinogenic action of urethane and this potentiation was 
blocked by injection of a  DNA  hydrolysate. 
Of the components and precursors of nucleic acids the pyrimidine series 
seemed especially  concerned.  Alterations in  the utilization  of  oxaloacetate, 
ureidosuccinic acid, dihydro-orotic acid, orotic acid, cytidylic  acid, and thymine 
appeared to  be  critical steps in  the oncogenic process,  following upon  the 
primary disorder of cellular metabolism initiated by the carcinogen. All these 
substances  except  oxaloacetate profoundly reduced the  number  of tumors 
initiated by urethane. Oxaloacetate potentiated the carcinogenic  effect. 
When these results are viewed together and in relation to known facts con- 
cerning nucleic acid synthesis they provide evidence suggesting that the point STANIqELD ROGERS  305 
of action of the carcinogen is in the pathway of nucleic acid synthesis below 
orotic acid and perhaps at the level of ureidosuccinic acid. 
The  potentiating  influence  of  adenine,  4-amino-S-imidazole  carboxamide, 
and aminopterin,  the lack of effect of uracil,  and the inhibitory  influence of 
thymine together suggest that DNA rather than RNA is the nucleic acid criti- 
cal to the oncogenic response of mice to urethane. 
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